The EviI proto-oncogene is required at midgestation for neural, heart, and paraxial mesenchyme development

Mechanisms of Development

Volumn 65, Issue 1-2, 1997, Pages 55-70

  Hoyt, Peter R ^a   Bartholomew, Christopher ^b   Davis, Amy J ^c   Yutzey, Katherine ^d   Gamer, Laura W ^e   Potter, S Steven ^d   Ihle, James N ^b   Mucenski, Michael L ^f  

^a University of Tennessee Oak Ridge Graduate School of Biomedical Sciences   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c PENNSYLVANIA STATE UNIVERSITY   (United States)

^d CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f OAK RIDGE NATIONAL LABORATORY   (United States)

Author keywords

Cell proliferation; Embryogenesis; EviI; Homologous recombination; Mouse

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR EVIL; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; EVI1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN GANGLION; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; EMBRYO; IN SITU HYBRIDIZATION; MESENCHYME; MESODERM; MOUSE; MULTIPLE MALFORMATION SYNDROME; NEURAL CREST; NONHUMAN; PRIORITY JOURNAL; PROTO ONCOGENE; SOMITE; ANIMAL; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HEART; MUTATION; PREGNANCY; PRENATAL DEVELOPMENT;

ANIMALS; DNA-BINDING PROTEINS; EMBRYONIC AND FETAL DEVELOPMENT; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEART; IN SITU HYBRIDIZATION; MESODERM; MICE; MUTATION; NEURAL CREST; PREGNANCY; PROTO-ONCOGENES; TRANSCRIPTION FACTORS;

EID: 0031173051     PISSN: 09254773     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4773(97)00057-9     Document Type: Article

References (62)

1. Ang, S.-L. and Rossant, J. (1994) HNF-3β is essential for node and notochord formation in mouse development. Cell 78, 561-574.
2. Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seidman, J.G., Smith, J.A. and Struhl, K. (1994) Current Protocols in Molecular Biology. Wiley, New York.
3. Bartholomew, C. and Clark, A.M. (1994) Induction of two alternatively spliced Evi1 proto-oncogene transcripts by cAMP in kidney cells. Oncogene 9, 939-942.
4. Bartholomew, C. and Ihle, J.N. (1991) Retroviral insertions 90 kilobases proximal to the Evi1 myeloid transforming gene activate transcription from the normal promoter. Mol. Cell. Biol. 11(4), 1820-1828.
5. Bordereaux, D., Fichelson, S., Tambourin, P. and Gisselbrecht, S. (1990) Alternative splicing of the Evi-1 zinc finger gene generates mRNAs which differ by the number of zinc finger motifs. Oncogene 5, 925-927.
6. Brannan, C.I., Perkins, A.S., Vogel, K.S., Ratner, N., Nordlund, M.L., Reid, S.W., Buchberg, A.M., Jenkins, N.A., Parada, L.F. and Copeland, N.G. (1994) Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes Dev. 8, 1019-1029.
7. Bromberg, M.E., Konigsberg, W.H., Madison, J.F., Pawashe, A. and Garen, A. (1995) Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation. Proc. Natl. Acad. Sci. USA 92, 8205-8209.
8. Bugge, T.H., Xiao, Q., Kombrinck, K.W., Flick, M.J., Holmback, K., Danton, M.J.S., Colbert, M.C., Witte, D.P., Fujikawa, K., Davie, E.W. and Degen, J.L. (1996) Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated, initiator of blood coagulation. Proc. Natl. Acad. Sci. USA 93, 6258-6263.
9. Charron, J., Malynn, B.A., Fisher, P., Stewart, V., Jeannotte, L., Goff, S.P., Robertson, E.J. and Alt, F.W. (1992) Embryonic lethality in mice homozygous for a targeted disruption of the N-myc gene. Genes Dev. 6, 2248-2257.
10. Crossley, P.H. and Martin, G.R. (1995) The mouse Fgf8 gene encodes a family of polypeptides and is expressed in regions that direct outgrowth and patterning in the developing embryo. Development 121, 439-451.
11. D'Amico-Martel, D. and Noden, D.M. (1983) Contributions of placodal and neural crest cells to avian cranial peripheral ganglia. Am. J. Anat. 166, 445-468.
12. Davis, A.C., Wims, M., Spotts, G.D., Hann, S.R. and Bradley, A. (1993) A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. Genes Dev. 7, 671-682.
13. Delwel, R., Funabiki, T., Kreider, B.L., Morishita, K. and Ihle, J.N. (1993) Four of the seven zinc fingers of the Evi-1 myeloid transforming gene are required for sequence-specific binding to GA(C/T)AAGA(T/ C)AAGATAA. Mol. Cell. Biol. 13(7), 4291-4300.
14. Dickson, M.C., Martin, J.S., Cousins, F.M., Kulkarni, A.B., Karlsson, S. and Akhurst, R.J. (1995) Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Development 121, 1845-1854.
15. Dumont, D.J., Gradwohl, G., Fong, G.-H., Puri, M.C., Gertsenstein, M., Auerbach, A. and Breitman, M.L. (1994) Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev. 8, 1897-1909.
16. Fichelson, S., Dreyfus, F., Berger, R., Melle, J., Bastard, C., Miclea, J.M. and Gisselbrecht, S. (1992) Evi-1 expression in leukemic patients with rearrangements of the 3q25-q28 chromosomal region. Leukemia 6(2), 93-99.
17. Field, S.J., Tsai, F.Y., Kuo, F., Zubiaga, A.M., Kaelin Jr., W.G., Livingston, D.M., Orkin, S. and Greenberg, M.E. (1996) E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85(4), 549-561.
18. Fong, G.H., Rossant, J., Gertsenstein, M. and Breitman, M.L. (1995) Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376, 66-70.
19. Funabiki, T., Kreider, B.L. and Ihle, J.N. (1994) The carboxyl domain of zinc fingers of the Evi-1 myeloid transforming gene binds a consensus sequence of GAAGATGAG. Oncogene 9, 1575-1581.
20. Garriga, G., Guenther, C. and Horvitz, H.R. (1993) Migrations of the Caenorhabditis elegans HSNs are regulated by egl-43, a gene encoding two zinc finger proteins. Genes Dev. 7, 2097-2109.
21. Hebert, J.M., Boyle, M. and Martin, G.R. (1991) mRNA localization studies suggest that murine FGF-5 plays a role in gastrulation. Development 112, 407-415.
22. Humason, G.L. (1972) Hematoxylin Staining. In Kennedy, D. and Park, R.B. (eds.), Animal Tissue Techniques, Freeman, San Francisco, pp. 148-169.
23. Ioffe, E. and Stanley, P. (1994) Mice lacking N-acetylglucosaminyltransferase 1 activity die at mid-gestation, revealing an essential role for complex or hybrid N-linked carbohydrates. Proc. Natl. Acad. Sci. USA 91, 728-732.
24. Jacks, T., Shih, S., Schmitt, E.M., Bronson, R.T., Bernards, A. and Weinberg, R.A. (1994) Tumour predisposition in mice heterozygous for a targeted mutation in Nfl. Nature Genet. 7, 353-361.
25. Jotterand Bellomo, M., Parlier V., Mühlematter, D., Grob, J.P. and Beris, P. (1992) Three new cases of chromosome 3 rearrangement in bands q21 and q26 with abnormal thrombopoiesis bring further evidence to the existence of a 3q21q26 syndrome. Cancer Genet. Cytogenet. 59, 138-160.
26. Kaufmann, M.H. (1992) The Atlas of Mouse Development, Academic Press, San Diego, CA.
27. Kawasaki, E.S. (1990) Amplification of RNA. In Innis, M.A., Gelfand, D.H., Sninsky, J.J. and White, T.J. (eds.), PCR Protocols, Academic Press, San Diego, pp. 21-27.
28. Khanna-Gupta, A., Lopingco, M.C., Savinelli, T., Zibello, T., Berliner, N. and Perkins, A.S. (1996) Retroviral insertional activation of the EVI 1 oncogene does not prevent G-CSF-induced maturation of the murine pluripotent cell line 32Dcl3. Oncogene 12, 563-569.
29. Kreider, B.L., Orkin, S.H. and Ihle, J.N. (1993) Loss of erythropoietin responsiveness in erythroid progenitors due to expression of the Evi-1 myeloid-transforming gene. Proc. Natl. Acad. Sci. USA 90, 6454-6458.
30. Kurokawa, M., Ogawa, S., Tanaka, T., Mitani, K., Yazaki, Y., Witte, O.N. and Hirai, H. (1995) The AML1/Evi-1 fusion protein in the t(3;21) translocation exhibits transforming activity on rat fibroblasts with dependence on the Evi-1 sequence. Oncogene 11, 833-840.
31. Levy, E.R., Parganas, E., Morishita, K., Fichelson, S., James, L., Oscier, D., Gisselbrecht, S., Ihle, J.N. and Buckle, V.J. (1994) DNA rearrangements proximal to the EVI1 locus associated with the 3q21q26 syndrome. Blood 83(5), 1348-1354.
32. Li, E., Bestor, T.H. and Jaenisch, R. (1992) Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69, 915-926.
33. Löhler, J., Timpl, R. and Jaenisch, R. (1984) Embryonic lethal mutation in mouse collagen 1 gene causes rupture of blood vessels and is associated with erythropoietic and mesenchymal cell death. Cell 38, 597-607.
34. Mackman, N. (1995) Regulation of the tissue factor gene. FASEB J. 9, 883-889.
35. Metzler, M., Gertz, A., Sarkar, M., Schachter, H., Schrader, J.W. and Marth, J.D. (1994) Complex asparagine-linked oligosaccharides are required for morphogenic events during post-implantation development. EMBO J. 13(9), 2056-2065.
36. Mitani, K., Ogawa, S., Tanaka, T., Miyoshi, H., Kurokawa, M., Mano, H., Yazaki, Y., Ohki, M. and Hirai, H. (1994) Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia. EMBO J. 13(3), 504-510.
37. Mitani, K., Ogawa, S., Tanaka, T., Kurokawa, M., Yazaki, Y. and Hirai, H. (1995) Growth inhibition of leukaemia cells carrying the t(3;21) by the AML1/Evi-1-specific antisense oligonucleotide. Br. J. Haematol. 90, 711-714.
38. Morishita, K., Parker, D.S., Mucenski, M.L., Jenkins, N.A., Copeland, N.G. and Ihle, J.N. (1988) Retroviral activation of a novel gene encoding a zinc finger protein in IL-3-dependent myeloid leukemia cell lines. Cell 54, 831-840.
39. Morishita, K., Parganas, E., Douglass, E.G. and Ihle, J.N. (1990a) Unique expression of the human Evi-1 gene in an endometrial carcinoma cell line: sequence of cDNAs and structure of alternatively spliced transcripts. Oncogene 5, 963-971.
40. Morishita, K., Parganas, E., Parham, D.M., Matsugi, T. and Ihle, J.N. (1990b) The Evi-1 zinc finger myeloid transforming gene is normally expressed in the kidney and in developing oocytes. Oncogene 5, 1419-1423.
41. Morishita, K., Parganas, E., Matsugi, T. and Ihle, J.N. (1992) Expression of the Evi-1 zinc finger gene in 32Dcl3 myeloid cells blocks granulocytic differentiation in response to granulocyte colony-stimulating factor. Mol. Cell. Biol. 12(1), 183-189.
42. Mucenski, M.L., Taylor, B.A., Ihle, J.N., Hartley, J.W., Morse, H.C. III, Jenkins, N.A. and Copeland, N.G. (1988) Identification of a common ecotropic viral integration site, Evi-1 in the DNA of AKXD murine myeloid tumors. Mol. Cell. Biol. 8(1), 301-308.
43. Mucenski, M.L., McLain, K., Kier, A.B., Swerdlow, S.H., Schreiner, C.M., Miller, T.A., Pietryga, D.W., Scott, W.J. and Potter, S.S. (1991) A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 65, 677-689.
44. Mullis, K.B. and Faloona, F.A. (1987) Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol. 155, 335-350.
45. Nucifora, G., Begy, C.R., Kobayashi, H., Roulston, D., Claxton, D., Pedersen-Bjergaad, J., Parganas, E., Ihle, J.N. and Rowley, J.D. (1994) Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations. Proc. Natl. Acad. Sci. USA 91, 4004-4008.
46. Oval, J., Smedsrud, M. and Taetle, R. (1992) Expression and regulation of the Evi-1 gene in human factor-dependent leukemia cell line, UCSD/ AML1. Leukemia 6(5), 446-451.
47. Perkins, A.S., Fishel, R., Jenkins, N.A. and Copeland, N.G. (1991a) Evi-1, a murine zinc finger proto-oncogene, encodes a sequence-specific DNA-binding protein. Mol. Cell. Biol. 11(5), 2665-2674.
48. Perkins, A.S., Mercer, J.A., Jenkins, N.A. and Copeland, N.G. (1991b) Patterns of Evi-1 expression in embryonic and adult tissues suggest that Evi-1 plays an important regulatory role in mouse development. Development 111, 479-487.
49. Robb, L., Lyons, I., Li, R., Hartley, L., Kontgen, F., Harvey, R.P., Metcalf, D. and Begley, C.G. (1995) Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene. Proc. Natl. Acad. Sci. USA 92, 7075-7079.
50. Russell, M., Thompson, F., Spier, C. and Taetle, R. (1993) Expression of the EVI1 gene in chronic myelogenous leukemia in blast crisis. Leukemia 7(10), 1654-1657.
51. Russell, M., List, A., Greenberg, P., Woodward, S., Glinsmann, B., Parganas, E., Ihle, J.N. and Taetle, R. (1994) Expression of EVI1 in myelodysplastic syndromes and other hematologic malignancies without 3q26 translocations. Blood 84(4), 1243-1248.
52. Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
53. Shalaby, F., Rossant, J., Yamaguchi, T.P., Gertsenstein, M., Wu, X.F., Breitman, M.L. and Schuh, A.C. (1995) Failure of blood-island formation and vasculogenesis in Flk-1-defecient mice. Nature 376, 62-66.
54. Shivdasani, R.A., Mayer, E.L. and Orkin, S.H. (1995) Absence of blood formation in mice lacking the T-cell leukemia oncoprotein tal-1/SCL. Nature 373, 432-434.
55. Sucov, H.M., Dyson, E., Gumeringer, C.L., Price, J., Chien, K.R. and Evans, R.M. (1994) RXRa mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis. Genes Dev. 8, 1007-1018.
56. Tanaka, T., Nishida, J., Mitani, K., Ogawa, S., Yazaki, Y. and Hirai, H. (1994) Evi-1 raises AP-1 activity and stimulates c-fos promoter trans-activation with dependence on the second zinc finger domain. J. Biol. Chem. 269(39), 24020-24026.
57. Tanaka, T., Mitani, K., Kurokawa, M., Ogawa, S., Tanaka, K., Nishida, J., Yazaki, Y., Shibata, Y. and Hirai, H. (1995) Dual functions of the AML1/Evi-1 chimeric protein in the mechanism of leukemogenesis in t(3;21) leukemias. Mol. Cell. Biol. 15(5), 2383-2392.
58. Tsai, F.-Y., Keller, G., Kuo, F.C., Weiss, M., Chen, J., Rosenblatt, M., Alt, F.W. and Orkin, S.H. (1994) An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature 371, 221-226.
59. Warren, A.J., Colledge, W.H., Carlton, M.B.L., Evans, M.J., Smith, A.J.H. and Rabbitts, T.H. (1994) The oncogenic cystein-rich LIM domain protein rbtn2 is essential for erythroid development. Cell 78, 45-57.
60. Weinstein, D.C., Ruiz i Altaba, A., Chen, W.S., Hoodless, P., Prezioso, V.R., Jessell, T.M. and Darnell, J.E. (1994) The winged-helix transcription factor HNF-3β is required for notochordal development in the mouse embryo. Cell 78, 575-588.
61. Wilkinson, D.G. (1992) Whole-mount in situ hybridization of vertebrate embryos. In Wilkinson, D.G. (ed.), In situ Hybridization: A Practical Approach, IRL Press, Oxford, pp. 75-83.
62. Yang, J.T., Rayburn, H. and Hynes, R.O. (1993) Embryonic mesodermal defects in alpha 5 integrin-deficient mice. Development 119, 1093-1105.